Drugs / Phycocyanin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07013890 | Nov 2022 → Aug 2023 | chronic prostatitis | Clinica Urologica Molinette - Città della Saliute e della Scienza | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phycocyanin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07013890 ↗ |
| Known as | spirulina platensis extract | “* phycocyanin (spirulina platensis extract) 250 mg” NCT07013890 ↗ |
| Route | Oral | “FICOXPEA® is an oral combination of Phycocyanin, Palmitoylethanolamide and selenium” NCT07013890 ↗ |